Retension Pharmaceuticals
Business Services · Virginia, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1104 W Broad St PMB 1064, Falls Church, ...Phone Number
(703) 940-9761Revenue
-Industry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Retension Pharmaceuticals
Retension Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company headquartered in Falls Church, Virginia, founded in 2023. The company is focused on developing innovative treatments for hypertension and other serious cardiovascular diseases. Its lead candidate, RTN-001, is a next-generation PDE5 inhibitor designed to enhance nitric oxide signaling in cardiovascular tissue, targeting patients with uncontrolled and resistant hypertension. Retension is currently advancing RTN-001 through a Phase 2b clinical trial and has recently filed for an initial public offering.Explore more
Retension Pharmaceuticals Org Chart
Get the full picture
Sign in to uncover key details.
Show More
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Retension Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Retension Pharmaceuticals is spiking on competitors!
Retension Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Retension Pharmaceuticals launches new products
Click to see if Retension Pharmaceuticals had a recent Job posting/layoffs
Earning: See what the market has to say on Retension Pharmaceuticals recently announced quarterly report
Check if Retension Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Retension Pharmaceuticals
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Retension Pharmaceuticals has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Retension Pharmaceuticals financials insights
Gather financial insights about Retension Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Series A
$10.4M
2025
Series B
$15M
Most Recent Scoops
New Hire
Executive Move
Executive Moves, New Hire
New Hire
Executive Move
Executive Moves, New Hire
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Retension Pharmaceuticals News & Media
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Retension Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Retension Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company headquartered in Falls Church, Virginia, founded in 2023. The company is focused on developing innovative treatments for hypertension and other serious cardiovascular diseases. Its lead candidate, RTN-001, is a next-generation PDE5 inhibitor designed to enhance nitric oxi... Read More
